Clinical trial
Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation
NCT00428233 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00428233 |
|---|---|
| Title | Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation |
| Official title | Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | Brigham and Women's Hospital |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Chronic Lymphocytic Leukemia |
| Intervention type | Procedure |
| Interventions | Leukemia cell harvest |
| Enrollment | 65 |
| Start date | Nov 1, 2006 |
| Primary completion | Jun 1, 2014 |
| Completion | Jun 1, 2014 |
| First posted | Jan 29, 2007 |
| Last update posted | Apr 8, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: